Showing results (91-100 of 92) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 92 results.
Lancet (London, England)|June 26, 2025
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trialJean Y Tang, M Peter Marinkovich, Karen Wiss, et al.The Lancet. Haematology|June 27, 2020
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trialNagesh Kalakonda, Marie Maerevoet, Federica Cavallo, et al.Pageof 10